Wayne, PA - May 15, 2006 Paradigm Spine, LLC ("Paradigm") completed the Company's $14 million Series C private placement. The private placement was handled by Viscogliosi & Co, Inc., an investment bank founded by Viscogliosi Brothers, LLC. Robin Hood Ventures participated in this round.

Paradigm is a leading provider of posterior stabilization technologies to the international spine community. The Company was founded in 2004 by Viscogliosi Brothers, LLC, a leading New York-based merchant banking firm specializing in the musculoskeletal/orthopedic sector. "I want to thank our investors for their support and for believing in the vision we are creating," said Marc R. Viscogliosi, Paradigm's Chairman and CEO. "With the close of this financing the Company is well funded and positioned to pursue our global vision. We intend to be the leading provider of indication-specific posterior non-fusion solutions that will provide surgeons with the best treatments to improve their patients' lives."

The proceeds from this financing will be used to drive further international expansion of the coflex(TM) technology, fund the Company's US clinical efforts involving the coflex(TM) device and the Orthobiom(TM) system, and to expand Paradigm's technology portfolio through organic product development or continued acquisition of spine non-fusion technologies and intellectual property.

About Paradigm Spine

The company is concentrating on building a multi- product non-fusion portfolio. One product is the coflex(TM) device, a posterior non-fusion interspinous dynamically-functional implant, which has a long clinical history of over a decade of use and has been implanted in more than 15,000 patients suffering from low back pain and lumbar spinal stenosis. Paradigm Spine's second core platform is the Orthobiom(TM) technology, also in development for over a decade. The Orthobiom (TM) technology treats adolescent idiopathic scoliosis, a condition in children which causes severe curvature of the spine and which is usually surgically treated with a spinal fusion procedure. The Orthobiom(TM) system is a non-fusion alternative designed to preserve the motion and growth of the child's spine. It is a revolutionary product that could potentially help the lives of tens of thousands of children each year.

About Robin Hood Ventures

Robin Hood Ventures is a membership organization of experienced entrepreneurs and accredited investors interested in investing and taking an active role in early stage companies with high return on investment potential. Robin Hood Ventures, founded in 1999, takes an innovative approach to angel investing. Member- established direct investment accounts create a pool of investable funds that enable rapid decision- making. Robin Hood's consistent approach to due diligence and deal structuring streamlines the deal process. Robin Hood Ventures invests as a single entity and considers business opportunities that represent the diverse interests and experience of our members.

Robin Hood focuses on investing in early stage companies located in the Mid-Atlantic region. Portfolio companies include Intellifit, Compoze, Power Medical Interventions, Etech Solutions, Inc., Fieldmaster Solutions, Glucolight, Baton, Synova Healthcare, Protez Pharmaceuticals, Bioconnect Systems, Baton Networks, Inc. and Paradigm Spine, LLC. As of April 2006, Robin Hood has invested approximately $10MM in 15 companies that have subsequently raised over $200 million.